Summary
The Netherlands Cancer Institute (NKI) is offering a fully funded PhD position focused on advancing adaptive radiotherapy for lung cancer treatment. This research aims to enhance treatment safety and efficacy using cutting-edge technology and methodologies.
PhD Student – CBCT-guided Adaptive Radiotherapy and Biological Monitoring in Lung Cancer, Netherlands Cancer Institute
Designation
PhD Student – CBCT-guided Adaptive Radiotherapy and Biological Monitoring in Lung Cancer
| Detail | Information |
|---|---|
| Research Area | Adaptive Radiotherapy, Medical Imaging, Cancer Biology |
| Location | Netherlands Cancer Institute (NKI) |
| Eligibility/Qualification | Master’s degree in Technical Medicine, Medicine, Biomedical Sciences, or a related field |
| Salary | €3,813 – €4,629 monthly |
| Contract Duration | 4 years (36 hours per week) |
| Application Deadline | May 15, 2026 |
Job Description
As a PhD candidate, your responsibilities will include:
- Developing and validating AI models for enhancing CBCT images.
- Designing studies to evaluate CBCT-based treatment adaptations.
- Conducting clinical validations of adaptive radiotherapy processes.
- Analyzing clinical data from the “Primer Shot” trials.
- Investigating biological markers of treatment response via liquid biopsies.
- Collaborating in an interdisciplinary team and sharing findings at conferences.
How to Apply
Interested candidates should submit the following:
- CV including projects, internships, and, if applicable, publications or conference abstracts.
- A cover letter detailing motivation for the position and relevant background.
- Contact information for two references.
Applications must be merged into one PDF file due to submission limits.
Last Date for Apply
May 15, 2026, 23:59 PM
For further queries, contact:
- Dr. Zeno Gouw: z.gouw@nki.nl
- Daphne Heemskerk (Application inquiries): d.heemskerk@nki.nl
This scholarship offers an exceptional opportunity to contribute to groundbreaking cancer research at a prestigious institution.
